Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency.

Although a final evaluation had shown a decreasing trend for JC viral load in the CSF, pembrolizumab was stopped as in view of the dramatic clinical deterioration, further treatment did not seem appropriate anymore.

also in 47,180 other papers